Publishing

Sole Author

• Gold MS. (1996).  Tabaco. Barcelona, Spain: Plenum
• Gold MS. (1995).  The good news about depression. New York, NY: Bantam Books
• Gold MS. (1995). Drugs of abuse: a comprehensive series for clinicians vol. IV Tobacco. New York and London: Plenum Medical Book Company
• Gold MS. (1993). Drugs of abuse: a comprehensive series for clinicians. vol. III Cocaine. New York and London: Plenum Medical Book Company
• Gold MS. (1991). The good news about drugs & alcohol. New York, NY: Villard Books
• Gold MS. (1991) Marihuana. de la edicion castellana, ediciones en neurociencias. Barcelona, Spain: Conde
• Gold MS (1990). The good news about panic, anxiety & phobias. New York, NY: Bantam Books
• Gold MS. (1989).  The good news about panic, anxiety & phobias. New York, NY: Villard Books
• Gold MS. (1987). Wonder drugs. New York, NY: Simon & Schuster
• Gold MS. (1986). The good news about depression. New York, NY: Random House
• Gold MS. (1987).  The facts about drugs and alcohol. New York, NY: Bantam Books
• Gold MS. (1986). The facts about drugs and alcohol. New York, NY: Bantam Books
• Gold MS. (1986). 800 Cocaine (revised). New York, NY: Bantam Books
• Gold MS. (1985). 800 Cocaine. (revised). New York, NY: Bantam Books
• Gold MS (1984).  800 Cocaine. New York, NY: Bantam Books
• Gold MS. (1988).  The good news about depression. New York, NH: Bantam Books
• Gold MS. (1986). Stop drugs at work: the solution/prevention. New York, NY: Random House

Co-Author

• Tyler S. Oesterle, Nuria J. Thusius A. Rummans, Mark S. Gold. (2019) Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings.
• Gold MS, Bensinger PB, Washton AM. (1986). Stop drugs at work: myths vs. facts. New York: Random House.
• Gold MS, Bensinger PB, Washton AM. (1986). Stop drugs at work: the solution/prevention program. New York: Random House.
• Miller NS, Gold MS. (1991). Drugs of abuse: a comprehensive series for clinicians. vol. II. alcohol. New York and London: Plenum Medical Book Company.
• Miller NS, Gold MS, Smith DE. (1997). Manual of therapeutics for addictions. New York, NY: Wiley-Liss.
• Blum K, Femino J, Teitelbaum S, Giordano J, Oscar-Berman M, Gold MS. (2013) Molecular Neurobiology of Addiction Recovery: The 12 Steps Program and Fellowship. New York, NY: SpringerBriefs in Neuroscience. 2013.

Editor/Co-Editor

• Psychosomatics, Co-Editor
• Psychiatry Letter, Co-Editor
• International Journal of Psychiatry in Medicine, Co-Editor
• Journal of Substance Abuse Treatment, Co-Editor
• Journal of Addictive Diseases, Co-Editor
• American Journal Drug & Alcohol Abuse, Co-Editor
• Crisis Intervention and Time-Limited Treatment, Co-Editor
• Addiction and Recovery, Contributing Editor
• Essential Psychopharmacology, Contributing Editor
• Psychiatric Annals, Contributing Editor
• Section Editor-Addictions- UpToDate and uptodate.com, July, 2000 – July, 2012
• Frontiers in Eating Behavior, Associate Editor, Aug 2012
• Journal of Addictive Diseases – Rapid Communications editor, July, 2013 – Present

Editorial Board(s)

• Principles of Addiction Medicine, Editorial Board
• Dual Disorders- Editorial Board
• Journal of Substance Abuse Treatment, Editorial Board
• Professional Counselor Magazine, Editorial Board
• The Journal of Dual Diagnosis-Editorial Board
• American Journal on Drug and Alcohol Abuse-Editorial Board
• Journal of Addictive Diseases-Editorial Board
• Findings (Betty Ford Center Newsletter)-Editorial Advisory Board Member through 2007
• PsycCRITIQUES, Editorial Board
• SciMat (Journal section of Betty Ford Center web site)-Editorial Advisory Board Member 2010 to May, 2013
• Advances in Integrative Omics and Applied Biotechnology, Editorial Board since 2011
• Current Addiction Reports, Editorial Board since 2014

Reviewer/Referee

• Addiction
• American Journal of Drug and Alcohol Abuse
• American Journal of Psychiatry
• Annals of Internal Medicine with Substance Use Disorders
• APA Practice Guideline – Treatment of Patients
• Archives of General Psychiatry
• Archives of Internal Medicine
• Biological Psychiatry
• Brain Research
• Depression
• Drug Development Research
• Experimental Brain Research
• Hospital and Community Psychiatry
• International Journal of Obesity
• Journal of Addiction Medicine
• Journal of Addictive Diseases
• Journal of the American Medical Association (JAMA)
• Journal of Caffeine Research
• Journal of Clinical Psychiatry and Drugs
• Journal of Clinical Psychopharmacology
• Grant reviewer for the Health Research Council of New Zealand, 2013
• Expert Opinion On Emerging Drugs, 2013
• Journal of Human Pharmacology and Drug Therapy
• Journal of Nervous and Mental Disease
• Journal of Neuropsychiatry and Clinical Neuroscience
• Journal of Psychiatric Research Perceptual Motor Skills
• Lancet
• Life Sciences
• Mayo Clinic Proceedings
• Medical Science Monitor International
• Medical Letter on the CDC & FDA
• Nature
• Nature reviews: Neuroscience
• Neuropsychopharmacology
• Pharmacology, Biochemistry and Behavior
• Pharmacotherapy
• Postgraduate Medicine
• Public Library of Science (PloS ONE)
• Psychoneuroendocrinology
• Psychopharmacology
• Psychosomatic Medicine
• Science
• Society for Experimental Biology and Medicine

Classic Publications
(Selected From >1,000 Peer Reviewed Papers, Books, Abstracts  Scientific articles )

• Zornetzer SF, Gold MS, Hendrikson J. (1974).  Alpha methylptyrosine and memory state dependency and memory failure. Behavioral Biology 12(1), 135-141.
• Zornetzer SF, Gold MS. (1976). The locus coeruleus: Its possible role in memory consolidation.Physiol Behav 16(3), 331-336.
• Gold MS, Byck R. (1978). Endorphins, lithium and naloxone: their relationship to pathological and drug induced manic euphoric states. Natl Inst Drug Abuse Res Monogr Ser 19,192-209.
• Gold MS, Washton AM, Dackis CA. (1985). Cocaine abuse: neurochemistry, phenomenology, and treatment. Natl Inst Drug Abuse Res Monogr Series 61,130-150.
• Washton AM, Gold MS,. (1985). Naltrexone in addicted physicians and business executives. Natl Inst Drug Abuse Res Monogr Series 55,185-190.
• Gold MS, Redmond Jr. DE, Kleber HD. (1978). Clonidine in opiate withdrawal. Lancet 1(8070), 929-930.
• .Gold MS, Redmond Jr. DE, Kleber HD. (1978). Clonidine blocks acute opiate withdrawal symptoms. Lancet 2(8090), 599-602.
• Gold MS, Redmond Jr. DE, Kleber HD. (1978). Clonidine may relieve opiate withdrawal symptoms. JAMA 240(23), 25-27.
• Gold MS, Bowers Jr. MB. (1978) Neurobiological vulnerability to low dose amphetamine psychosis. Am J Psychiatry 135(12), 1546-1548.
• Gold MS, Kleber HD. (1979). A rationale for opiate withdrawal symptomatology. Drug Alcohol Depend 4(5),419-424.
• Gold MS, Byck R, Sweeney DR, Kleber HD. (1979). Endorphin locus coeruleus connection mediates opiate action and withdrawal. Biomedicine 30(1), 1-4.
• Kleber HD, Gold MS, Riordan CE. (1980) The use of clonidine in detoxification from opiates.Bull Narc 32(2),1-10.
• Gold MS,et al . (1982). Naltrexone, opiate addiction and endorphins. Med Res Rev 2(3),211-246.
• Gold MS, Pearsall HR. (1983).  Hypothyroidism  or is it depression? Psychosomatics, 24(7),646-657.
• Cohen MR, Pickar D, Extein I, Gold MS, Sweeney DR. (1984). Plasma cortisol and beta endorphin immunoreactivity in nonmajor and major depression. Am J Psychiatry 141(5),628-632.
• Gold MS, Dackis CA, Washton AM. (1984). The sequential use of clonidine and naltrexone in the treatment of opiate addicts, Adv Alcohol Subst Abuse, 3(3),19-39.
• Gold MS, Verebey K. (1984). The psychopharmacology of cocaine. Psychiatric Annals14(10),714-723.
• Gold MS, Dackis CA. (1985). New insights and treatments: narcotics and cocaine addiction. Clin Ther 7(1),6-21.
• Dackis CA, Gold MS. (1985). Pharmacological approaches to cocaine addiction. J Subst Abuse Treat 2,139-145.
• Dackis CA, Gold MS. (1985). New concepts in cocaine addiction: the dopamine depletion hypothesis. Neuroscience and Biobehavioral Reviews 9(3),469-477.
• Verebey K, Gold MS, Mule SJ. (1986). Laboratory testing in the diagnosis of marijuana intoxication and withdrawal. Psychiatric Annals 16(4),235-241.
• Gold MS, Roehrich H. (1987). Treatment of opiate withdrawal with clonidine. ISI Atlas of Science: Pharmacology 1741,29-32.
• Verebey K, Martin D, Gold MS. (1987). Interpretation of drug abuse testing: strengths and limitations of current methodology. Psychiatr Med 3(3),287-297.
• Gold MS, Galanter M, Stimmel B. (1987). Cocaine: a new epidemic. Adv Alcohol Subst Abuse6(2),1-5.
• Jonas JM, Gold MS. (1988). The use of opiate antagonists in treating bulimia: a study of low dose versus high dose naltrexone. Psychiatry Res 24,195-199
• Verebey K, Gold MS. (1988). From coca leaves to crack: The effects of dose and routes of administration in abuse liability. Psychiatric Annals 18(9),513-520.
• Miller NS, Gold MS. (1991). Dual diagnoses: Psychiatric syndromes in alcoholism and drug addiction. Am Fam Physician 43(6),2071-2076.
• Gold MS. (1992) Are eating disorders addictions? Neuro Endocrinol Lett 14(4), 229.
• Miller NS, Gold MS. (1994). Dissociation of “conscious desire” (craving) from and relapse in alcohol and cocaine dependence.  Ann Clin Psychiatry 2,99-106.
• Dupont RL, Gold MS. (1995). Withdrawal and reward: implications for detoxification and relapse prevention Psychiatric Annals 25(11), 663-668.
• Liu Y, Gold MS. (2003). Human fMRI of eating and satiety in eating disorders and obesity. Psychiatric Annals. 33(2), 127-132.
• Tullis LM, Frost-Pineda K, Dupont R, Gold MS. (2003) Marijuana and tobacco: a connection.  J Add Dis. 22(3), 51-62.
• Szabo ST, Gold MS, Goldberger BA and Blier P. (2004) Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons. Biol Psychiatry 55,934-939.
•  Bruijnzeel AW and Gold MS. (2005). The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Rev. 49(3), 505-528.
• Jacobs, WS, Repetto M, Vinson S, Pomm R, Gold MS. (2004). Random urine testing as an intervention for drug addiction. Psychiatric Annals  34(10),781-785.
• Coleman JJ, Bensinger PB, Gold MS, Smith DE, Dupont Rim Bianchi RP. (2006).Can drug design inhibit use? J Psychoactive Drugs. 37(4), 342-362.
• McCusker RR, Fuehrlein B, Goldberger BA, Gold MS, Cone EJ. (2006). Technical brief: caffeine content of decaffeinated coffee J Anal Toxicol 30(8) 611-613.
•  Warren MW, Kobeissy FH, Liu MC, Hayes RL, Gold MS, Wang, KKW. (2006).  Ecstasy
• Bruijnzeel AW, Zislis G, Wilson C, Gold MS. (2007). Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 32(4) 955-963.
• Gold MS, Merlo L. (2007). Performance Enhancing Medications and Drugs of Abuse. J Addict Disease 25(S1),1-3.
• Graham N, Gold MS. (2007). Performance enhancing, non-prescription use of erectile dysfunction  medications.  J Addict Disease 25 (S1), 61-68.
•  Rylkova D, Bruijnzeel AW, Gold MS. (2007) Anabolic steroid abuse: neurobiological substrates and psychiatric comorbidity. J Addict Disease 25 (S1), 33-45.
• Martin DM, Baron D, Gold MS. (2007).The spread of performance-enhancing drugs from professional sports to adolescents, weekend athletes and non-athletes. J Addict Disease. 25(S1), 5-15.
•  Miller NS, Gold MS. (2007). Opiate perscription medication dependence and pain perceptions. J Addict Dis. 26(S1):65-71.
• Dupont RL, Gold MS. (2008). Comorbidity and “self-medication”. J Addict Disease 26(S1), 13-24.
•  Hodgkins C, Frost-Pineda K, Gold MS. (2008). Weight Gain during substance abuse treatment: the dual problem of addiction and overeating in an adolescent population. J Addict Disease26(S1), 41-50.
• Sekine Y, Ouchi Y Sugihara G, Takei N, Yoshikawa E, Nakamura K, Iwata Y, Tsuchiya KJ, Suda S, Suzuki K, Kawai M, Takebayashi K, Yamamoto S, Matsuzaki H, Mori N, Gold MS, Cadet JL. (2008). Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 28(22) 5756-5761.
• Merlo LJ, Gold MS. (2008). Special Report- Frontiers in psychiatric research: Addiction research: The state of the art in 2008.  Psychiatric Times 25(7), 52-57.
• Liu J, Pan H, Gold MS, Derendorf H, Bruijnzeel AW (2008). Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats.Neuropharmacology  55(5):812-818.
• Cocores JA, Gold MS. (2008). Varenicline, Appetite, and Weight Reduction. The Journal of Neuropsychiatry and Clinical Neurosciences, 20(4):497-498.
• DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. (2009). Setting the standard for recovery: Physicians’ Health Programs. J Subst Abuse Treat; 36(2):159-171.
• von Deneen KM, Gold MS, Liu Y. (2009) Food Addiction and Cues in Prader-Willi Syndrome. J Addict Med 3(1):19-25.
• Gold MS, Graham NA, Cocores JA, Nixon SJ. (2009).  Editorial: Food Addiction?  J Addict Med 3(1):42-45.
• Gold MS, Kobeissy FH, Wang KKW, Merlo LJ, Bruijnzeel AW, Krasnova IN, Cadet JL. (2009). Methamphetamine- and Trauma-Induced Brain Injuries: Comparative Cellular and Molecular Neurobiological Substrates. Biological Psychiatry, 66(2): 118-127.
• Merlo LJ, Gold MS. (2009 – Aug 28). Successful Treatment of Physicians with Addictions: Addiction Impairs More Physicians Than Any Other Disease. Psychiatric Times, 26(9):1-8.
• Small E, Shah HP, Davenport JJ, Geier JE, Yavarovich KR, Yamada H, Sabarinath SN, Derendorf H, Pauly JR, Gold MS, Bruijnzeel AW. (2010) Tobacco smoke exposure induces nicotine dependence in rats. Psychopharmacology (Berl). 208(1):143-158. [Epub ahead of print Nov 21 2009].  PMID: 19936715
• Blumenthal DM, Gold MS. (2010). Neurobiology of Food Addiction. Current Opinion in Clinical Nutrition and Metabolic Care; 13:359-365.
• Goldberger BA, Martin DM, Gold MS. Opium Smoke: The Study of Second- and Third-Hand Exposure in Women and Children in Afghanistan. In: Afghanistan National Urban Drug Use Survey 2012. (pgs  A96-A103). U.S. Department of State, Bureau of International Narcotics and Law Enforcement Affairs: Washington, DC
• Goldberger BA, Martin DM, Gold MS. Afghanistan Treatment Center Study: Children’s Hair, Oral Fluid, and Urine Random Drug Testing. In: Afghanistan National Urban Drug Use Survey 2012. (pgs  A104-A126). U.S. Department of State, Bureau of International Narcotics and Law Enforcement Affairs: Washington, DC
• Greene W, Gold MS. Section 16: Drug Abuse (pgs 946-951). In Edward T. Bope & Rick D. Kellerman (Eds.) Conn’s Current Therapy 2015. Saunders, Inc: Philadelphia, PA.

2020 Dr. Gold’s Academic Peer-Reviewed Medical Scientific Journal Publications 

• Swenson S, Blum K, McLaughlin T, Gold MS, Thanos PR, The therapeutic potential of exercise for neuropsychiatric diseases: A review. J Neurol Sci. 2020 May 15; 412:116763. doi: 10.1016/j.jns.2020.116763. Epub 2020 Mar 4. PMID 32305746 Review
• Gold M, Medicinal Marijuana, Stress, Anxiety, and Depression: Primum non nocere, Mo Med. 2020 Sept-Oct; 117(5): 406-411. PMID 33311739 Free PMC article. Review. No abstract available.
• El Hayek S, Allouch F, Razafsha M, Talih F, Gold MS, Wang KK, Kobeissy F., Traumatic brain injury and methamphetamine: A double-hit neurological insult. J Neurol Sci. 2020 April 15; 411:116711. doi 10.1016/j.jns.2020.116711. Epub 2020 Jan 30. PMID: 32035311 Review
• Paterson Silver Wolf DA, Gold M, Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. JNeurol Sci. 2020 Apr 15; 411:116718. doi: 10.1016/j.jns.2020.116718. Epub 202 Feb 5. PMID: 32078842 Review.
• Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T, J Neurol Sci. 2020 Apr 15;411:116719. doi: 10.1016/j.jns.2020.116719. Epub 2020 Jan 31. PMID 32070807 Review
• Oesterle TS, Kolla B, Risma CJ, Breitinger SA, Rakacevic DB, Loukianova LL, Hall-Flavin DK, Gentry MT, Rummans TA, Chauhan M, Gold MS, Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era: A New Outlook, Mayo Clin Proc. 2020 Dec;95(12):2709-2718. doi: 10.1016/j.mayocp.2020.10.011. Epub 2020 Oct 21, PMID 33276643 Free PCM article. Review.
• Oesterle TS, Kolla PP, Rummans TA, Gold MS. Medication-assisted therapies for opioid use disorders in patients with chronic pain. J Neurol Sci. 2020 Apr 15;411:116728. doi 10.1016/j.jns.2020.116728. Epub 2020 Feb 11. PMID: 32092625 Review
• Wiss DA, Avena N, Gold M, Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications. Nutrients. 2020 Nov 16:12(11):3521. doi. 10.3390/nu12113521. PMID: 33207612 Free PCM article. Review.
• Blum K, Cadet JL, Gold MS, Psychostimulant use disorder emphasizing methamphetamine and the opioid-dopamine connection: Digging out of a hypodopaminergic ditch. J Neurol Sci. 2020 Nov 28 420:117252. doi: 10.1016/j.jns.2020.117252. Online ahead of print. PMID: 33279726 Review.
• Blum K, Baron D, Mclaughlin T, Gold MS, Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphineric deficiency syndrome (EDS). J Neurol Sci. 2020 Apr 15;411;116733. doi: 10.1016/j.jns.2020.116733. Epub 2020 Feb 14. PMID: 32099516 Review.
• Gold MS, Baron D, Bowirrat A, Blum K, Neurologica correlates of brain reward circuity linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? J Neurol Scie. 2020 Nov 16; 418:117137. doi: 10.1016/j.jns. 2020. 117137. Epub 2020 Sep 16. PMID: 32957037 Free PMC article. Review.
• Blum K, Cadet JL, Baron D, Badgaiyan RD, Brewer R, Modestino EJ, Gold MS, Putative COVID-19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addiction with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? Subst Use Misuse. 2020;55(14): 2438-2442. doi: 10.1080/10826084.2020. 1817086. Epub 2020 Sep 22. PMID: 32957797 Review.
• Gold MS, The Role of Alcohol, Drugs, and Deaths of Despair in the U.S.’s Falling Life Expectancy. MO Med. 2020 Mar-Apr 117(2):99-101. PMID: 32308224 Free PMC article. No abstract available.
• Blum K, Lott L, Baron D, Smith DE, Badgaivan RD, Gold MS, Improving naltrexone compliance and outcomes with putative pro-dopamine regulator KB220, compared to treatment as usual. J Syst Integr Neurosci. 2020 May 30;7:10.15761/JSIN.1000229. doi:10.15761/JSIN.1000229. PMID: 32934823 Free PMC article
• Gold MS, Cadet JL, Baron D, Badgaivan RD, Blum K, Calvin Klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge of a potential death sentance. J Syst Integr Neurosci. 2020 Apr 24;7:10.15761/JSIN.1000227. doi. 10.15761/JSIN.100227. PMID: 32934822 Free PMC article. No abstract available.

2019 Dr Mark Gold receives Addiction Policy Forum Pillar of Excellence Award for Research

(2010-2019) Dr. Gold’s Academic Peer-Reviewed Medical Scientific Journal Publications 

• Oesterle TS, Kolla BP, Rummans TA Gold MS. Medication-assisted therapies for opioid use disorders in patients with chronic pain. J Neurol Sci. 2020 Feb 11;411:116728. doi: 10.1016/j.jns.2020.116728. [Epub ahead of print] Review. PMID: 32092625
• Blum K, Baron D, McLaughlin T, Gold MS. Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS). J Neurol Sci. 2020 Feb 14;411:116733. doi: 10.1016/j.jns.2020.116733. [Epub ahead of print] Review. PMID: 32088516
• Paterson Silver Wolf DA, Gold M. Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. J Neurol Sci. 2020 Feb 5;411:116718. doi: 10.1016/j.jns.2020.116718. [Epub ahead of print] Review. PMID: 32078842
• Kolla BP, Oesterle T, Gold M, Southwick F, Rummans T. Infectious diseases occurring in the context of substance use disorders: A concise review. J Neurol Sci. 2020 Jan 31;411:116719. doi: 10.1016/j.jns.2020.116719. [Epub ahead of print] Review. PMID: 32070807
• El Hayek S, Allouch F, Razafsha M, Talih F, Gold MS, Wang KK, Kobeissy F. Traumatic brain injury and methamphetamine: A double-hit neurological insult. J Neurol Sci. 2020 Jan 30;411:116711. doi: 10.1016/j.jns.2020.116711. [Epub ahead of print] Review. PMID: 32035311
• Tyler S. Oesterle, Nuria J. Thusius A. Rummans, Mark S. Gold. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clinic Proceedings. Mayo Clin Proc. 2019 Oct;94(10):2072-2086. doi: 10.1016/j.mayocp.2019.03.029. Epub 2019 Sep 19. Review. PMID: 31543255
• Blum K, Baron D, Badgaiyan RD, Gold MS. Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carries of the DRD2 A1 Allele in Cocaine Abuse? EC Psychol Psychiatr. 2019 Apr 15;8(5):318-321. No abstract available. PMID:31276119. Free PMC Article
• Srivastava AB, Kobeissy FH, Gold MS. Qualitative vs Quantitative Methods in Psychiatric Research: Updated. Methods Mol Biol. 2019;2011:23-37. doi: 10.1007/978-1-4939-9554-7_2. PMID: 31273691
• Srivastava AB, Gold MS (2019) Naltrexone: A History and Future Directions Cerebrum. 2018 Sep 1;2018. pii: cer-13-18. eCollection 2018 Sep-Oct. PMID: 30746025 Free PMC Article
• Small E, Shah HP, Davenport JJ, Geier JE, Yavarovich KR, Yamada H, Sabarinath SN, Derendorf H, Pauly JR, Gold MS, Bruijnzeel AW. (2010) Tobacco smoke exposure induces nicotine dependence in rats. Psychopharmacology (Berl). 208(1):143-158. [Epub ahead of print Nov 21 2009]. PMID: 19936715
• Fuller BF, Gold MS, Wang KK, Ottens AK. (2010). Effects of environmental tobacco smoke on adult rat brain biochemistry. J Mol Neurosci. May; 41(1):165-71. [Dec 4 2009-Epub ahead of print]. PMID: 19960371
• Blum K, Chen TJH, Chen ALH, Madigan M, Downs BW, Waite RL, Braverman ER, Kerner M, Bowirrat A, Giordano J, Henshaw H, Gold MS. (2010). Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). Medical Hypotheses, 74(3): 513-520. PMID: 19914781
• Blumenthal DM, Gold MS. (2010). Neurobiology of Food Addiction. Current Opinion in Clinical Nutrition and Metabolic Care; 13:359-365.
• Yuan K, Qin W, Liu J, Guo Z, Dong M, Sun J, Zhang Y, Liu P, Wang W, Wang Y, Li W, Yang W, von Deneen KM, Gold MS, Liu Y, Tian J. Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals. Neurosci Lett. 2010; 477(1): 37-42.
• Yuan K, Qin W, Dong M, Liu J, Sun J, Liu P, Zhang Y, Wang W, Wang Y, Li Q, Zhao L, von Deneen KM, Liu Y, Gold MS, Tian J. Gray matter deficits and resting-state abnormalities in abstinent heroin-dependent individuals. Neurosci Lett; 2010;482(2):101-5.
• Bowirrat A, Chen TJH, Madigan M, Bailey JA, Chen ALC, Downs BW, Braverman ER, Gold MS, Radi S, Waite RL, Kerner M, Giordano J, Morse S, Oscar-Berman M, and Blum K. Neuro-psychopharmacogenetics and Neurological antecedents of PostTraumatic Stress Disorder: Unlocking the mysteries of resilience and vulnerability. Current Neuropharmacology. 2010; 8(4): 335-358.
• Shriner RL, Graham NA, Gold MS. Smoking cessation and the risk for type 2 diabetes mellitus. Ann Intern Med. 2010; 152(11):755.
• Liu Y, von Deneen KM, Kobeissy FH, Gold MS. Food Addiction and Obesity: Evidence from Bench to Bedside. Journal of Psychoactive Drugs. 2010; 42(2):133-151.
• Blumenthal DM, Gold MS. Neurobiology of food addiction. Curr Opin Clin Nutr Metab Care. 2010;13(4):359-365.
• Kobeissy FH, Sadasivan S, Buchanan M, Zhang Z, Gold MS, Wang KK. Methods in systems biology of experimental methamphetamine drug abuse. Methods Mol Biol. 2010; 662:303-16.
• Bailey JA, Hurley RW, Gold MS. Crossroads of Pain and Addiction. Pain Medicine. (Malden, Mass) 2010; 11:1803-18.
• Bailey JA, Hurley RW, Gold MS. Co-Managing chronic pain and addictive disorders. ASRA [serial on the Internet]. 2010 [cited 01 DEC 2010] Available at: http://asra.com/pain-resource-center-chronic-pain-co-managing-chronic-pain-and-addictive-disorders.php
• Blum K and Gold MS. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: A hypothesis. Medical Hypotheses. 2011; 76(4):576-84.
• Merlo LJ, Ahmedani BK, Bardondess DA, Bohnert KM, Gold MS. Alcohol consumption associated with collegiate American football pre-game festivities. Drug Alcohol Depend. 2011 Jul 1;116(1-3):242-5.
• DuPont RL, McLellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: Physicians’ Health Programs. May 3, 2011 – Posted by Betty Ford Institute in Resources, under Continuing Care. Can be found at: http://www.bettyfordinstitute.org/publications Originally published in J Subst Abuse Treat 2009; 36(2):159-171.
• Zhang Y, von Deneen KM, Tian J, Gold MS, Liu Y. Food Addiction and Neuroimaging. Curr Pharm Des. 2011; 17(12):1149-57. PMID: 21492080.
• Gold J, Gold MS. Exercise for the Overweight and Obese. Curr Pharm Des. 2011; 17(12):1193-7. PMID: 21492089.
• Edge PJ, Gold MS. Drug Withdrawal and Hyperphagia: Lessons from Tobacco and Other Drugs. Curr Pharm Des. 2011; 17(12):1173-9. PMID: 21492091.
• Blum K, Liu Y, Shriner R, Gold MS. Reward circuitry dopaminergic activation regulates food and drug craving behavior. Curr Pharm Des. 2011;17(12):1158-67. PMID: 21492092.
• Gold, MS. From Bedside to Bench and Back Again: A 30-year Saga. Physiol Behav. 2011; 104(1):157-161. PMID: 21530563.
• Avena NM, Gold MS. Food and addiction – sugars, fats and hedonic overeating. Addiction. 2011; 106(7):1214-5. PMID 21635590.
• Avena NM, Gold MS. Variety and hyperpalatability: are they promoting addictive overeating? Am J Clin Nutr. 2011; 94:367-8. PMID: 21715513.
• Guingab-Cagmat JD, Stevens SM Jr, Ratliff MV, Zhang Z, Gold MS, Anagli J, Wang KK, Kobeissy FH. (2011) Identification of tyrosine nitration in UCH-L1 and GAPDH. Electrophoresis. 2011; 32(13):1692-705.
• Zhang Y, Tian J, Yuan K, Liu P, Zhuo L, Qin W, Zhao L, Liu J. von Deneen KM, Klahr NJ, Gold MS, Liu Y. Distinct resting-state brain activities in heroin-dependent individuals. Brain Res. 2011;1402:46-53. PMID: 21669407.
• Johnson RJ, Gold MS, Johnson DR, Ishimoto T, Lanaspa MA, Zahniser NR, Avena NM. Attention Deficit-Hyperactivity Disorder: Is it time to reappraise the role of sugar consumption? Postgraduate Medicine. 2011 Sep; 123(5):39-49.
• Carnes PJ, Green BA, Merlo LJ, Polles A, Carnes S, Gold MS. PATHOS: A brief screening application for assessing sexual addiction. J Addict Med. 2011 Aug 3; [Epub ahead of print].
• Avena N, Wang M, Gold MS. Implications of food addiction and drug use in obesity. Psychiatric Annals. 2011 Oct.; 41(10): 478-482.
• Skidmore F, Yang M, Baxter L, von Deneen K, Collingwood J, He G, Tandon R, Korenkevych D, Savenkov A, Heilman K, Gold M, Liu Y. Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage. 2011 Jul 14;
• Skidmore FM, Yang M, Baxter L, von Deneen KM, Collingwood J, He G, White K, Korenkevych D, Savenkov A, Heilman KM, Gold M, Liu Y. Reliability analysis of the resting state can sensitively and specifically identify the presence of Parkinson disease. Neuroimage. 2011 Sep 20;
• von Deneen KM, Wei Q, Peng L, Hao DM, Peng C, Xie H, Tian J, Gold MS, Liu Y. Randomized fMRI trial of the central effects of acute acupuncture on glucose levels and core body temperature in “overweight” males. Medical Acupuncture. 2011; 23(3):165-173.
• Avena NM, Bocarsly ME, Hoebel BG, Gold MS. Overlaps in the nosology of substance abuse and overeating: the translational implications of “food addiction”. Curr Drug Abuse Rev. 2011; 4:133-9.
• Klahr NJ, Wright P, Guangming L, Merlo L, Zhang Y, Guojun He, Gold MS, Liu Y. Investigating the effects of low dose alcohol on neural timing using functional MRI. Journal of Magnetic Resonance Imaging. 2011; 34:1045-52.
• Avena NM, Gold J, Kroll C, Gold MS. Further Developments in the Neurobiology of Food and Addiction: Update on the State of the Science. Nutrition. 2011; doi:10.1016/j.nut.2011.11.002. [Epub ahead of print].
• Blum K, Gardner E, Oscar-Berman M, Gold M. “Liking” and “Wanting” Linked to Reward Deficiency Syndrome (RDS): Hypothesizing Differential Responsivity in Brain Reward Circuitry. Current Pharmaceutical Design. 2012; 18(1):113-118. [Jan 9 Epub ahead of print]
• Blum K, Tucker D, Bowirrat A, Barh D, Braverman ER, Oscar-Berman M, Giordano J, Simpatico T, and Gold M. Depressed dopamine function in attention deficit/hyperactivity disorder (ADHD): should genotyping of dopaminergic and other gene polymorphisms constitute early diagnosis in children? Integrative Omics and Molecular Biology. 2012;1(1):1-27.
• Blum K, Werner T, Carnes S, Carnes P, Bowirrat A, Giordano J, Gold M. Sex, Drugs and Rock ‘N’ Roll: Hypothesizing common mesolimbic activation as a function of reward gene polymorphisms. Journal Psychoactive Drugs. 2012; 44(1):38-55.
• Blum K, Bailey J, Gonzales AM, Oscar-Berman M, Liu Y, Giordano J, Braverman E, Gold M. Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the root cause of “addiction transfer”: A new phenomena common after bariatric surgery. J Genet Syndr Gene Ther. 2011 Dec 23; 2012; S2:001. doi: 10.4172/2157-7412.S2-001.
• Archer T, Oscar-Berman M, Blum K, Gold M. Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry. J Genet Syndr Gene Ther. 2012; 3(3):1000115. doi: 10.4172/2157-7412.1000115.
• Reisfield GM, Goldberger BA, Gold MS, DuPont RL. The Mirage of Impairing Drug Concentration Thresholds: A Rationale for Zero Tolerance Per Se Driving under the Influence of Drug Laws. Journal of Analytical Toxicology. 2012; 36:353-356.
• Brownell K, Gold M. Food products. Addiction. Also in the mind. [Commentary] World Nutrition. 2012 Sep: 3(9):392-405.
• Nias M and Gold MS. Junk Food, Globesity, and Food Addiction. Invited feature article for Counselor magazine. 2012 October; 13(5):46-49.
• Guingab-Cagmat J, Bauzo RM, Bruijnzeel AW, Wang KK, Gold MS, Kobeissy FH. Methods in tobacco abuse: proteomic changes following second-hand smoke exposure. Methods in molecular biology 2012; 829:329-348.
• Xu G, Stevens SM Jr, Kobeissy F, Brown H, McClung S, Gold MS, Borchelt DR. Identification of proteins sensitive to thermal stress in human neuroblastoma and glioma cell lines. PloS ONE, 2012 Nov; 7(11):e49201. [Epub 2012 Nov 8.]
• Zhang Y, Zhao H, Qiu S, Tian J, Wen X, Miller JL, von Deneen KM, Zhou Z, Gold MS, and Liu Y. Altered functional brain networks in Prader-Willi syndrome. NMR in Biomed 2013. Doi: 10.1002/nbm.2900
• Kobeissy F, Alawich A, Mondello S, Boustany RM, Gold MS. Biomarkers in psychiatry: how close are we? Frontiers in Psychiatry 2013; Epub Jan. 7. Doi: 10.3389/fpsyt.2012.00114.
• Avena NM, Murray S, Gold MS. Comparing the effects of food restriction and overeating on brain reward systems. Experimental Gerontology. 2013 Mar 24. Pii: S0531-5565(13)00083-1. [Epub ahead of print].
• Yarnell S, Oscar-Berman M, Avena NM, Blum K, Gold MS. Pharmacotherapies for Overeating and Obesity. J Genet Syndr Gene Ther. 2013 April 1; 4(3):131-. doi: 10.4172/2157-7412.1000131.
• Cottler LB, Aijnkya S, Merlo LJ, Nixon SJ, Abdallah AB, Gold MS. Lifetime Psychiatric and Substance Use Disorders Among Impaired Physicians in a Physicians Health Program: Comparison to a General Treatment Population. Journal of Addiction Medicine. 2013 May 2; 7(2): 108-112. doi: 10.1097/ADM.0b013e31827fadc9.
• Razafsha M, Behforuzi H, Harati H, Al Wafai R, Khaku A, Mondello S, Gold MS, Kobeissy FH. An Updated Overview of Animal Models in Neuropsychiatry. Neuroscience, 2013 Mar 6; pii: S0306-4522(13)00186-3. Doi: 10.1016/J.neuroscience.2013.02.045. [Epub ahead of print].
• Archer T, Oscar-Berman M, Blum K, and Gold MS. Epigenetic Modulation of Mood Disorders. J Genet Syndr Gene Ther. 2013 Feb 11; 4(120). doi: 10.4172/2157-7412.1000120.
• Gold MS, Avena NM. Animal models lead the way to further understanding food addiction as well as providing evidence that drugs used successfully in addictions can be successful in treating overeating. [Letter] Biol Psychiatry, 2013. doi: 10.1016/j.biopsych.2013.04.022.
• Blum K, Oscar-Berman M, Barh D, Giordano J, Gold MS. Dopamine Genetics and Function in Food and Substance Abuse. Journal of Genetic Syndromes & Gene Therapy, 2013; 4(121). doi: 10.4172/2157-7412.1000121.
• Krasnova IN, Chiflikyan M, Justinova Z, McCoy MT, Ladenheim B, Jayanthi S, Quintero C, Brannock C, Barnes C, Adair JE, Lehrmann E, Kobeissy FH, Gold MS, Becker KG, Goldberg SR, Cadet JL. CREB Phosphorylation Regulates Striatal Transcriptional Responses in the Self-Administration Model of Methamphetamine Addiction in the Rat. Neurobiology of Disease 2013, doi: 10.1016/jbd.2013.05.009
• Shriner RL, Gold MS. Is your patient addicted to food? Obesity Consults. 2013 June;1(1): 8-10.
• Blum K, Foster OM, Wang KK, Febo M, Borsten J, Giordano J, Hauser M, Gold MS. Hypothesizing that designer drugs containing cathinones (“bath salts”) have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. Med Hypotheses. 2013 Jul 8; pii: S0306-9877(13)00285-5. doi: 10.1016/j.mehy.2013.06.007. [Epub ahead of print]
• Avena NM, Bocarsly ME, Murray S, Gold MS. The effects of baclofen and naltrexone, alone and in combination, on overeating of palatable food in rats. Experimental and Clinical Psychopharmacology (submitted 21 Aug 2013).
• Cottler LB, Ajinkya S, Goldberger BA, Ghani MA, Martin DM, Gold MS. The Prevalence of Drug and Alcohol Use in Afghanistan: Data from the Afghanistan National Urban Drug Use Study (ANUDUS). (to be submitted)
• Xu G, Guingab-Cagmat J, Gold MS, Kobaissy F, Borchelt D. Newly synthesized proteins are differentially sensitive to proteostasis stressors. Molecular BioSystems (submitted Feb 12, 2013)
• Merlo LJ, Sutton JA, Gold MS. Brief educational intervention to improve medical student competence in managing patients exposed to secondhand smoke. Substance Abuse. [Epub ahead of print] doi: 10.1080/7077.2013.821438.
• Avena NM, Murray S, Gold MS. The next generation of obesity treatments: beyond suppressing appetite. Frontiers in Psychology. 2013; 4(721): 1-3.

1.	Hatching the behavioral addiction egg: Reward Deficiency Solution System (RDSS)™ as a function of dopaminergic neurogenetics and brain functional connectivity linking all addictions under a common rubric.
	Blum K, Febo M, McLaughlin T, Cronjé FJ, Han D, Gold SM.
	J Behav Addict. 2014 Sep;3(3):149-56. doi: 10.1556/JBA.3.2014.019. Epub 2014 Aug 26. Review.
	PMID: 25317338 [PubMed] Free PMC Article
	Related citations

2.	Prevalence of drug and alcohol use in urban Afghanistan: epidemiological data from the Afghanistan National Urban Drug Use Study (ANUDUS).
	Cottler LB, Ajinkya S, Goldberger BA, Ghani MA, Martin DM, Hu H, Gold MS.
	Lancet Glob Health. 2014 Oct;2(10):e592-600. doi: 10.1016/S2214-109X(14)70290-6.
	PMID: 25304635 [PubMed – in process] Free Article
	Related citations

3.	Dopamine and glucose, obesity, and reward deficiency syndrome.
	Blum K, Thanos PK, Gold MS.
	Front Psychol. 2014 Sep 17;5:919. doi: 10.3389/fpsyg.2014.00919. eCollection 2014. Review.
	PMID: 25278909 [PubMed] Free PMC Article
	Related citations

4.	Systematic evaluation of “compliance” to prescribed treatment medications and “abstinence” from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs.
	Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS.
	PLoS One. 2014 Sep 23;9(9):e104275. doi: 10.1371/journal.pone.0104275. eCollection 2014.
	PMID: 25247439 [PubMed – in process] Free PMC Article
	Related citations

5.	Predicting subsequent relapse by drug-related cue-induced brain activation in heroin addiction: an event-related functional magnetic resonance imaging study.
	Li Q, Li W, Wang H, Wang Y, Zhang Y, Zhu J, Zheng Y, Zhang D, Wang L, Li Y, Yan X, Chang H, Fan M, Li Z, Tian J, Gold MS, Wang W, Liu Y.
	Addict Biol. 2014 Sep 11. doi: 10.1111/adb.12182. [Epub ahead of print]
	PMID: 25214465 [PubMed – as supplied by publisher]
	Related citations

6.	Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment.
	Wang Y, Wang H, Li W, Zhu J, Gold MS, Zhang D, Wang L, Li Y, Yan X, Cheng J, Li Q, Wang W.
	Neurosci Lett. 2014 Oct 3;581:120-4. doi: 10.1016/j.neulet.2014.08.026. Epub 2014 Aug 23.
	PMID: 25157798 [PubMed – in process]
	Related citations

7.	Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats.
	Avena NM, Bocarsly ME, Murray S, Gold MS.
	Exp Clin Psychopharmacol. 2014 Oct;22(5):460-7. doi: 10.1037/a0037223. Epub 2014 Jul 28.
	PMID: 25069013 [PubMed – in process]
	Related citations

8.	Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function.
	Blum K, Oscar-Berman M, Badgaiyan R, Braverman ER, Gold MS.
	Psychology (Irvine). 2014 Mar;5(4):282-288.
	PMID: 25009759 [PubMed] Free PMC Article
	Related citations

9.	Hormonal and neural mechanisms of food reward, eating behaviour and obesity.
	Murray S, Tulloch A, Gold MS, Avena NM.
	Nat Rev Endocrinol. 2014 Sep;10(9):540-52. doi: 10.1038/nrendo.2014.91. Epub 2014 Jun 24. Review.
	PMID: 24958311 [PubMed – indexed for MEDLINE]
	Related citations

10.	Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS).
	Blum K, Oscar-Berman M, Demetrovics Z, Barh D, Gold MS.
	Mol Neurobiol. 2014 May 31. [Epub ahead of print]
	PMID: 24878765 [PubMed – as supplied by publisher]
	Related citations

11.	Brief educational intervention to improve medical student competence in managing patients exposed to secondhand smoke.
	Merlo LJ, Sutton JA, Gold MS.
	Subst Abus. 2014;35(2):163-7. doi: 10.1080/08897077.2013.821438.
	PMID: 24821353 [PubMed – in process]
	Related citations

12.	Human traumatic brain injury induces autoantibody response against glial fibrillary acidic protein and its breakdown products.
	Zhang Z, Zoltewicz JS, Mondello S, Newsom KJ, Yang Z, Yang B, Kobeissy F, Guingab J, Glushakova O, Robicsek S, Heaton S, Buki A, Hannay J, Gold MS, Rubenstein R, Lu XC, Dave JR, Schmid K, Tortella F, Robertson CS, Wang KK.
	PLoS One. 2014 Mar 25;9(3):e92698. doi: 10.1371/journal.pone.0092698. eCollection 2014.
	PMID: 24667434 [PubMed – in process] Free PMC Article
	Related citations

13.	Food consumption and weight gain after cessation of chronic amphetamine administration.
	Orsini CA, Ginton G, Shimp KG, Avena NM, Gold MS, Setlow B.
	Appetite. 2014 Jul;78:76-80. doi: 10.1016/j.appet.2014.03.013. Epub 2014 Mar 22.
	PMID: 24667154 [PubMed – in process]
	Related citations

14.	Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior.
	Blum K, Oscar-Berman M, Badgaiyan RD, Palomo T, Gold MS.
	Med Hypotheses. 2014 May;82(5):606-14. doi: 10.1016/j.mehy.2014.02.019. Epub 2014 Feb 26.
	PMID: 24636783 [PubMed – in process]
	Related citations

15.	Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?
	Gold MS, Blum K, Oscar-Berman M, Braverman ER.
	Postgrad Med. 2014 Jan;126(1):153-77. doi: 10.3810/pgm.2014.01.2735. Review.
	PMID: 24393762 [PubMed – indexed for MEDLINE] Free PMC Article
	Related citations

16.	The next generation of obesity treatments: beyond suppressing appetite.
	Avena NM, Murray S, Gold MS.
	Front Psychol. 2013 Oct 9;4:721. doi: 10.3389/fpsyg.2013.00721. eCollection 2013. No abstract available.
	PMID: 24130541 [PubMed] Free PMC Article
	Related citations